科兴制药：第二届董事会第二十八次会议决议公告

Group 1 - The core point of the article is that Kexing Pharmaceutical announced the approval of several proposals, including the use of part of the raised funds to provide interest-free loans to its wholly-owned subsidiary for the implementation of fundraising projects [2] Group 2 - The announcement was made during the 28th meeting of the second board of directors [2] - The decision reflects the company's strategy to support its subsidiary in executing investment projects [2] - The funding mechanism involves utilizing raised capital, indicating a focus on internal resource allocation for growth [2]